Key result
Sinopharm COVID-19 vaccine linked to a reversible case of acute myocarditis and heart failure.
Why the study?
Increased myocarditis and pericarditis cases have been reported after mRNA and adenovirus vector-based COVID-19 vaccination, but a similar pattern had not been observed after inactivated virus vaccines.
Case Report (n=1)
This case report documents a rare occurrence of acute myocarditis following an inactivated SARS-CoV-2 vaccine, an adverse event previously associated primarily with mRNA and adenovirus vector vaccines.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to possible myocarditis after inactivated COVID-19 vaccines; extends prior reports but remains hypothesis-generating from one case.
During the Coronavirus disease 2019 (COVID-19) pandemic, vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has proven to be an important measure to help control disease spread and improve patient outcome. There are four distinct vaccine categories: inactivated viral vaccines, messenger RNA (mRNA) vaccines, adenovirus vector-based vaccines, and adjuvanted protein vaccines. In 2021, increased cases of myocarditis and pericarditis were reported after mRNA and adenovirus vector-based COVID-19 vaccination. A similar reporting pattern has not been observed after receipt of inactivated virus vaccines. Here, we present a case of clinically suspected acute myocarditis in a 26-year-old female, occurring 11 days after the administration of Sinopharm Vero Cell, an inactivated virus COVID-19 vaccine. This event led to acute heart failure, with marked clinical resolution observed within 34 days.
No takes yet. Share an insight, caveat, or question.
Vũ et al. (2023) conducted a case report in clinically suspected acute myocarditis (n=1). Sinopharm Vero Cell inactivated COVID-19 vaccine was evaluated. Sinopharm Vero Cell inactivated COVID-19 vaccine administration was followed 11 days later by acute myocarditis and heart failure in a 26-year-old female, with clinical resolution within 34 days.
Synapse has enriched 10 related papers. Consider them for comparative context: